{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:04:17Z","timestamp":1790701457871,"version":"4.1.0"},"reference-count":145,"publisher":"IMR Press","issue":"9","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Anhui Provincial Scientific Research Planning Project","award":["2023AH050796"],"award-info":[{"award-number":["2023AH050796"]}]},{"name":"Talent support Program of Anhui University of  Chinese Medicine","award":["2023rcyb002"],"award-info":[{"award-number":["2023rcyb002"]}]},{"name":"PI team of the School of Traditional Chinese Medicine, Anhui University of Chinese Medicine","award":["2024zyky04"],"award-info":[{"award-number":["2024zyky04"]}],"id":[{"id":"https:\/\/ror.org\/02my3bx32","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Heart failure (HF) is major and growing global health challenge, with lipid metabolism dysregulation recognized as a significant contributing factor. This review focuses on the emerging concept of the \u201cmetabolism-senescence axis\u201d, which plays a central role in disease development progression. Excess lipid metabolites, especially ceramides and diacylglycerols, contribute to cardiomyocyte injury through multiple mechanisms, including mitochondria dysfunction, promoting oxidative stress, and interfering with normal metabolic signals. The senescence-associated secretory phenotype (SASP) promotes a pro-senescent tissue microenvironment, thereby disrupting the normal metabolic balance and creating a vicious cycle that seriously affects heart structure and function. This review examines the molecular events underlying this process, including cellular injury, impaired fatty acid oxidation, oxidative stress, activation of the p53\/p21 and p16INK4a\/Rb, signaling pathways, and SASP-mediated metabolic dysfunction. We further discuss the rationale for combinatorial strategies targeting both metabolic dysfunction and cellular senescence, proposing that simultaneous intervention in these interconnected pathways may represent a promising therapeutic approach to delay the progression of HF and improve patient outcomes.<\/jats:p>","DOI":"10.31083\/fbl48959","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:21:51Z","timestamp":1790698911000},"source":"Crossref","is-referenced-by-count":0,"title":["Heart Failure: Lipid Metabolism Disorders Driving Cellular Senescence Through a Vicious Cycle, and Possible Intervention Strategies"],"prefix":"10.31083","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6829-4962","authenticated-orcid":true,"given":"Wei","family":"He","sequence":"first","affiliation":[{"name":"First Clinical Medical College, Anhui University of Chinese Medicine, 230038 Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9222-0323","authenticated-orcid":true,"given":"Pan","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Anhui University of Chinese Medicine, 230012 Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7850-0657","authenticated-orcid":true,"given":"Jingjing","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Anhui University of Chinese Medicine, 230031 Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8653-0736","authenticated-orcid":true,"given":"Qing","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Anhui University of Chinese Medicine, 230012 Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1784-0204","authenticated-orcid":true,"given":"Yangqi","family":"Zhao","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Anhui University of Chinese Medicine, 230038 Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2278-3777","authenticated-orcid":true,"given":"Ran","family":"Xia","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Anhui University of Chinese Medicine, 230012 Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"ref1","unstructured":"Hu SS, Wang ZW. Summary of the \"Report on Cardiovascular Health and Diseases in China 2022\". Chinese Journal of Cardiac Critical Care. 2023; 21: 577\u2013600. (In Chinese)"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023; 147: e93\u2013e621.","DOI":"10.1161\/CIR.0000000000001123"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Baman JR, Ahmad FS. Heart Failure. JAMA. 2020; 324: 1015.","DOI":"10.1001\/jama.2020.13310"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Capone F, Sotomayor-Flores C, Bode D, Wang R, Rodolico D, Strocchi S, et al. Cardiac metabolism in HFpEF: from fuel to signalling. Cardiovascular Research. 2023; 118: 3556\u20133575.","DOI":"10.1093\/cvr\/cvac166"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nature Reviews. Cardiology. 2017; 14: 591\u2013602.","DOI":"10.1038\/nrcardio.2017.65"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Li Y, Wu X, Pan J, Gong L, Min D. Hepatocyte steatosis activates macrophage inflammatory response accelerating atherosclerosis development. Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences. 2023; 52: 751\u2013765.","DOI":"10.3724\/zdxbyxb-2023-0315"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Omasa T, Okuyama S, Sawamoto A, Nakajima M, Furukawa Y. Effects of Citrus kawachiensis Peel in Frailty-like Model Mice Induced by Low Protein Nutrition Disorders. Antioxidants (Basel, Switzerland). 2023; 12: 779.","DOI":"10.3390\/antiox12030779"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"De Cauwer A, Loustau T, Erne W, Pichot A, Molitor A, Stemmelen T, et al. Dicer1 deficient mice exhibit premature aging and metabolic perturbations in adipocytes. iscience. 2022; 25: 105149.","DOI":"10.1016\/j.isci.2022.105149"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Yamamoto T, Sano M. Deranged Myocardial Fatty Acid Metabolism in Heart Failure. International Journal of Molecular Sciences. 2022; 23: 996.","DOI":"10.3390\/ijms23020996"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Zhou J, Chong SY, Lim A, Singh BK, Sinha RA, Salmon AB, et al. Changes in macroautophagy, chaperone-mediated autophagy, and mitochondrial metabolism in murine skeletal and cardiac muscle during aging. Aging. 2017; 9: 583\u2013599.","DOI":"10.18632\/aging.101181"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Cieslik KA, Sekhar RV, Granillo A, Reddy A, Medrano G, Heredia CP, et al. Improved Cardiovascular Function in Old Mice After N-Acetyl Cysteine and Glycine Supplemented Diet: Inflammation and Mitochondrial Factors. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2018; 73: 1167\u20131177.","DOI":"10.1093\/gerona\/gly034"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Bonen A, Han XX, Habets DDJ, Febbraio M, Glatz JFC, Luiken JJFP. A null mutation in skeletal muscle FAT\/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism. American Journal of Physiology. Endocrinology and Metabolism. 2007; 292: E1740\u2013E1749.","DOI":"10.1152\/ajpendo.00579.2006"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Chen J, Aronowitz P. Congestive Heart Failure. The Medical Clinics of North America. 2022; 106: 447\u2013458.","DOI":"10.1016\/j.mcna.2021.12.002"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Barger PM, Kelly DP. PPAR signaling in the control of cardiac energy metabolism. Trends in Cardiovascular Medicine. 2000; 10: 238\u2013245.","DOI":"10.1016\/s1050-1738(00)00077-3"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Da Dalt L, Cabodevilla AG, Goldberg IJ, Norata GD. Cardiac lipid metabolism, mitochondrial function, and heart failure. Cardiovascular Research. 2023; 119: 1905\u20131914.","DOI":"10.1093\/cvr\/cvad100"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Li W, Yao M, Wang R, Shi Y, Hou L, Hou Z, et al. Profile of cardiac lipid metabolism in STZ-induced diabetic mice. Lipids in Health and Disease. 2018; 17: 231.","DOI":"10.1186\/s12944-018-0872-8"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Puri K, Lal N, Shang R, Ghosh S, Flibotte S, Dyer R, et al. Diabetes Mellitus Severity and a Switch From Using Lipoprotein Lipase to Adipose-Derived Fatty Acid Results in a Cardiac Metabolic Signature That Embraces Cell Death. Journal of the American Heart Association. 2019; 8: e014022.","DOI":"10.1161\/JAHA.119.014022"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Zhang Y, Bharathi SS, Beck ME, Goetzman ES. The fatty acid oxidation enzyme long-chain acyl-CoA dehydrogenase can be a source of mitochondrial hydrogen peroxide. Redox Biology. 2019; 26: 101253.","DOI":"10.1016\/j.redox.2019.101253"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Acosta-Monta\u00f1o P, Rodr\u00edguez-Vel\u00e1zquez E, Ibarra-L\u00f3pez E, Frayde-G\u00f3mez H, Mas-Oliva J, Delgado-Coello B, et al. Fatty Acid and Lipopolysaccharide Effect on Beta Cells Proteostasis and its Impact on Insulin Secretion. Cells. 2019; 8: 884.","DOI":"10.3390\/cells8080884"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Dong S, Zhang R, Liang Y, Shi J, Li J, Shang F, et al. Changes of myocardial lipidomics profiling in a rat model of diabetic cardiomyopathy using UPLC\/Q-TOF\/MS analysis. Diabetology & Metabolic Syndrome. 2017; 9: 56.","DOI":"10.1186\/s13098-017-0249-6"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Wu T, Huang T, Ren H, Shen C, Qian J, Fu X, et al. Metabolic Coordination Structures Contribute to Diabetic Myocardial Dysfunction. Circulation Research. 2025; 136: 946\u2013967.","DOI":"10.1161\/CIRCRESAHA.124.326044"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Li H, Fan J, Zhao Y, Zhang X, Dai B, Zhan J, et al. Nuclear miR-320 Mediates Diabetes-Induced Cardiac Dysfunction by Activating Transcription of Fatty Acid Metabolic Genes to Cause Lipotoxicity in the Heart. Circulation Research. 2019; 125: 1106\u20131120.","DOI":"10.1161\/CIRCRESAHA.119.314898"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Kienesberger PC, Pulinilkunnil T, Nagendran J, Dyck JRB. Myocardial triacylglycerol metabolism. Journal of Molecular and Cellular Cardiology. 2013; 55: 101\u2013110.","DOI":"10.1016\/j.yjmcc.2012.06.018"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Suzuki J, Shen WJ, Nelson BD, Patel S, Veerkamp JH, Selwood SP, et al. Absence of cardiac lipid accumulation in transgenic mice with heart-specific HSL overexpression. American Journal of Physiology. Endocrinology and Metabolism. 2001; 281: E857\u2013E866.","DOI":"10.1152\/ajpendo.2001.281.4.E857"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Zheng P, Xie Z, Yuan Y, Sui W, Wang C, Gao X, et al. Plin5 alleviates myocardial ischaemia\/reperfusion injury by reducing oxidative stress through inhibiting the lipolysis of lipid droplets. Scientific Reports. 2017; 7: 42574.","DOI":"10.1038\/srep42574"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Pollak NM, Schweiger M, Jaeger D, Kolb D, Kumari M, Schreiber R, et al. Cardiac-specific overexpression of perilipin 5 provokes severe cardiac steatosis via the formation of a lipolytic barrier. Journal of Lipid Research. 2013; 54: 1092\u20131102.","DOI":"10.1194\/jlr.M034710"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J, et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science (New York, N.Y.). 2006; 312: 734\u2013737.","DOI":"10.1126\/science.1123965"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Harris CA, Haas JT, Streeper RS, Stone SJ, Kumari M, Yang K, et al. DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytes. Journal of Lipid Research. 2011; 52: 657\u2013667.","DOI":"10.1194\/jlr.M013003"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Liu L, Trent CM, Fang X, Son NH, Jiang H, Blaner WS, et al. Cardiomyocyte-specific loss of diacylglycerol acyltransferase 1 (DGAT1) reproduces the abnormalities in lipids found in severe heart failure. The Journal of Biological Chemistry. 2014; 289: 29881\u201329891.","DOI":"10.1074\/jbc.M114.601864"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Lin LC, Liu ZY, Yang JJ, Zhao JY, Tao H. Lipid metabolism reprogramming in cardiac fibrosis. Trends in Endocrinology and Metabolism: TEM. 2024; 35: 164\u2013175.","DOI":"10.1016\/j.tem.2023.10.004"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Liu Q, Siloto RMP, Lehner R, Stone SJ, Weselake RJ. Acyl-CoA:diacylglycerol acyltransferase: molecular biology, biochemistry and biotechnology. Progress in Lipid Research. 2012; 51: 350\u2013377.","DOI":"10.1016\/j.plipres.2012.06.001"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Zhao M, Bian R, Xu X, Zhang J, Zhang L, Zheng Y. Sphingolipid Metabolism and Signalling Pathways in Heart Failure: From Molecular Mechanism to Therapeutic Potential. Journal of Inflammation Research. 2025; 18: 5477\u20135498.","DOI":"10.2147\/JIR.S515757"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Liu L, Shi X, Bharadwaj KG, Ikeda S, Yamashita H, Yagyu H, et al. DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity. The Journal of Biological Chemistry. 2009; 284: 36312\u201336323.","DOI":"10.1074\/jbc.M109.049817"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Ballard FB, Danforth WH, Naegle S, Bing RJ. Myocardial metabolism of fatty acids. The Journal of Clinical Investigation. 1960; 39: 717\u2013723.","DOI":"10.1172\/JCI104088"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Fucho R, Casals N, Serra D, Herrero L. Ceramides and mitochondrial fatty acid oxidation in obesity. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology. 2017; 31: 1263\u20131272.","DOI":"10.1096\/fj.201601156R"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Schulze PC. Myocardial lipid accumulation and lipotoxicity in heart failure. Journal of Lipid Research. 2009; 50: 2137\u20132138.","DOI":"10.1194\/jlr.R001115"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Bikman BT, Summers SA. Ceramides as modulators of cellular and whole-body metabolism. The Journal of Clinical Investigation. 2011; 121: 4222\u20134230.","DOI":"10.1172\/JCI57144"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Holland WL, Bikman BT, Wang LP, Yuguang G, Sargent KM, Bulchand S, et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. The Journal of Clinical Investigation. 2011; 121: 1858\u20131870.","DOI":"10.1172\/JCI43378"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"D'Souza K, Nzirorera C, Kienesberger PC. Lipid metabolism and signaling in cardiac lipotoxicity. Biochimica et Biophysica Acta. 2016; 1861: 1513\u20131524.","DOI":"10.1016\/j.bbalip.2016.02.016"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Stratford S, Hoehn KL, Liu F, Summers SA. Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt\/protein kinase B. The Journal of Biological Chemistry. 2004; 279: 36608\u201336615.","DOI":"10.1074\/jbc.M406499200"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Powell DJ, Hajduch E, Kular G, Hundal HS. Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)\/Akt by a PKCzeta-dependent mechanism. Molecular and Cellular Biology. 2003; 23: 7794\u20137808.","DOI":"10.1128\/MCB.23.21.7794-7808.2003"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Park TS, Hu Y, Noh HL, Drosatos K, Okajima K, Buchanan J, et al. Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. Journal of Lipid Research. 2008; 49: 2101\u20132112.","DOI":"10.1194\/jlr.M800147-JLR200"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Miura A, Kajita K, Ishizawa M, Kanoh Y, Kawai Y, Natsume Y, et al. Inhibitory effect of ceramide on insulin-induced protein kinase Czeta translocation in rat adipocytes. Metabolism: Clinical and Experimental. 2003; 52: 19\u201324.","DOI":"10.1053\/meta.2003.50011"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Jaeschke A, Davis RJ. Metabolic stress signaling mediated by mixed-lineage kinases. Molecular Cell. 2007; 27: 498\u2013508.","DOI":"10.1016\/j.molcel.2007.07.008"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Galadari S, Rahman A, Pallichankandy S, Galadari A, Thayyullathil F. Role of ceramide in diabetes mellitus: evidence and mechanisms. Lipids in Health and Disease. 2013; 12: 98.","DOI":"10.1186\/1476-511X-12-98"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Sathyanarayana P, Barthwal MK, Kundu CN, Lane ME, Bergmann A, Tzivion G, et al. Activation of the Drosophila MLK by ceramide reveals TNF-alpha and ceramide as agonists of mammalian MLK3. Molecular Cell. 2002; 10: 1527\u20131533.","DOI":"10.1016\/s1097-2765(02)00734-7"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Xu Z, Maroney AC, Dobrzanski P, Kukekov NV, Greene LA. The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis. Molecular and Cellular Biology. 2001; 21: 4713\u20134724.","DOI":"10.1128\/MCB.21.14.4713-4724.2001"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Kanety H, Hemi R, Papa MZ, Karasik A. Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. The Journal of Biological Chemistry. 1996; 271: 9895\u20139897.","DOI":"10.1074\/jbc.271.17.9895"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Ola A, Kerkel\u00e4 R, Tokola H, Pikkarainen S, Skoumal R, Vuolteenaho O, et al. The mixed-lineage kinase 1-3 signalling pathway regulates stress response in cardiac myocytes via GATA-4 and AP-1 transcription factors. British Journal of Pharmacology. 2010; 159: 717\u2013725.","DOI":"10.1111\/j.1476-5381.2009.00567.x"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Chen CL, Lin CF, Chang WT, Huang WC, Teng CF, Lin YS. Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway. Blood. 2008; 111: 4365\u20134374.","DOI":"10.1182\/blood-2007-08-106336"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nature Reviews. Molecular Cell Biology. 2008; 9: 139\u2013150.","DOI":"10.1038\/nrm2329"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S, et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity. 2012; 36: 401\u2013414.","DOI":"10.1016\/j.immuni.2012.01.009"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Kawai T, Akira S. TLR signaling. Seminars in Immunology. 2007; 19: 24\u201332.","DOI":"10.1016\/j.smim.2006.12.004"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Zhang LX, Zhao Y, Cheng G, Guo TL, Chin YE, Liu PY, et al. Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition. American journal of physiology. Heart and circulatory physiology. 2010; 298: H2154\u2013H2163.","DOI":"10.1152\/ajpheart.01015.2009"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Zhao T, He L, Wong LP, Mei S, Xia J, Xu Y, et al. Derepressing nuclear pyruvate dehydrogenase induces therapeutic cancer cell reprogramming. Cell Metabolism. 2025; 37: 1667\u20131681.e13.","DOI":"10.1016\/j.cmet.2025.05.009"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Pettus BJ, Chalfant CE, Hannun YA. Ceramide in apoptosis: an overview and current perspectives. Biochimica et Biophysica Acta. 2002; 1585: 114\u2013125.","DOI":"10.1016\/s1388-1981(02)00331-1"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Auge N, Garcia V, Maupas-Schwalm F, Levade T, Salvayre R, Negre-Salvayre A. Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor\/PI-3 kinase\/Akt and the sphingolipid signaling pathways. Arteriosclerosis, Thrombosis, and Vascular Biology. 2002; 22: 1990\u20131995.","DOI":"10.1161\/01.atv.0000043453.21629.3b"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Abdalla S, Fu X, Elzahwy SS, Klaetschke K, Streichert T, Quitterer U. Up-regulation of the cardiac lipid metabolism at the onset of heart failure. Cardiovascular & Hematological Agents in Medicinal Chemistry. 2011; 9: 190\u2013206.","DOI":"10.2174\/187152511797037583"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Dookun E, Walaszczyk A, Redgrave R, Palmowski P, Tual-Chalot S, Suwana A, et al. Clearance of senescent cells during cardiac ischemia-reperfusion injury improves recovery. Aging Cell. 2020; 19: e13249.","DOI":"10.1111\/acel.13249"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Walaszczyk A, Dookun E, Redgrave R, Tual-Chalot S, Victorelli S, Spyridopoulos I, et al. Pharmacological clearance of senescent cells improves survival and recovery in aged mice following acute myocardial infarction. Aging Cell. 2019; 18: e12945.","DOI":"10.1111\/acel.12945"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Salerno N, Marino F, Scalise M, Salerno L, Molinaro C, Filardo A, et al. Pharmacological clearance of senescent cells improves cardiac remodeling and function after myocardial infarction in female aged mice. Mechanisms of Ageing and Development. 2022; 208: 111740.","DOI":"10.1016\/j.mad.2022.111740"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Witham MD, Granic A, Miwa S, Passos JF, Richardson GD, Sayer AA. New Horizons in cellular senescence for clinicians. Age and Ageing. 2023; 52: afad127.","DOI":"10.1093\/ageing\/afad127"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Booth LK, Redgrave RE, Tual-Chalot S, Spyridopoulos I, Phillips HM, Richardson GD. Heart Disease and Ageing: The Roles of Senescence, Mitochondria, and Telomerase in Cardiovascular Disease. Sub-cellular Biochemistry. 2023; 103: 45\u201378.","DOI":"10.1007\/978-3-031-26576-1_4"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Booth LK, Redgrave RE, Folaranmi O, Gill JH, Richardson GD. Anthracycline-induced cardiotoxicity and senescence. Frontiers in Aging. 2022; 3: 1058435.","DOI":"10.3389\/fragi.2022.1058435"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Dookun E, Passos JF, Arthur HM, Richardson GD. Therapeutic Potential of Senolytics in Cardiovascular Disease. Cardiovascular Drugs and Therapy. 2022; 36: 187\u2013196.","DOI":"10.1007\/s10557-020-07075-w"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Kim KH, Park B, Rhee DK, Pyo S. Acrylamide Induces Senescence in Macrophages through a Process Involving ATF3, ROS, p38\/JNK, and a Telomerase-Independent Pathway. Chemical Research in Toxicology. 2015; 28: 71\u201386.","DOI":"10.1021\/tx500341z"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Anderson EJ, Kypson AP, Rodriguez E, Anderson CA, Lehr EJ, Neufer PD. Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart. Journal of the American College of Cardiology. 2009; 54: 1891\u20131898.","DOI":"10.1016\/j.jacc.2009.07.031"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Kienesberger PC, Pulinilkunnil T, Nagendran J, Young ME, Bogner-Strauss JG, Hackl H, et al. Early structural and metabolic cardiac remodelling in response to inducible adipose triglyceride lipase ablation. Cardiovascular Research. 2013; 99: 442\u2013451.","DOI":"10.1093\/cvr\/cvt124"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Chang WT, Wu CY, Lin YC, Wu MT, Su KL, Yuan SS, et al. C2-Ceramide-Induced Rb-Dominant Senescence-Like Phenotype Leads to Human Breast Cancer MCF-7 Escape from p53-Dependent Cell Death. International Journal of Molecular Sciences. 2019; 20: 4292.","DOI":"10.3390\/ijms20174292"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, Appella E, et al. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. The EMBO Journal. 1999; 18: 6845\u20136854.","DOI":"10.1093\/emboj\/18.23.6845"},{"key":"ref71","unstructured":"Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Molecular Cancer Therapeutics. 2002; 1: 639\u2013649."},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, Liu Y, et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metabolism. 2007; 5: 167\u2013179.","DOI":"10.1016\/j.cmet.2007.01.002"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"de Mello VDF, Lankinen M, Schwab U, Kolehmainen M, Lehto S, Sepp\u00e4nen-Laakso T, et al. Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease. Diabetologia. 2009; 52: 2612\u20132615.","DOI":"10.1007\/s00125-009-1482-9"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Chokshi A, Drosatos K, Cheema FH, Ji R, Khawaja T, Yu S, et al. Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure. Circulation. 2012; 125: 2844\u20132853.","DOI":"10.1161\/CIRCULATIONAHA.111.060889"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Steinberg SF. Structural basis of protein kinase C isoform function. Physiological Reviews. 2008; 88: 1341\u20131378.","DOI":"10.1152\/physrev.00034.2007"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Li Y, Soos TJ, Li X, Wu J, Degennaro M, Sun X, et al. Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101). The Journal of Biological Chemistry. 2004; 279: 45304\u201345307.","DOI":"10.1074\/jbc.C400186200"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Murriel CL, Mochly-Rosen D. Opposing roles of delta and epsilonPKC in cardiac ischemia and reperfusion: targeting the apoptotic machinery. Archives of Biochemistry and Biophysics. 2003; 420: 246\u2013254.","DOI":"10.1016\/j.abb.2003.08.038"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Samstad EO, Niyonzima N, Nymo S, Aune MH, Ryan L, Bakke SS, et al. Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release. Journal of Immunology (Baltimore, Md.: 1950). 2014; 192: 2837\u20132845.","DOI":"10.4049\/jimmunol.1302484"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010; 464: 1357\u20131361.","DOI":"10.1038\/nature08938"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"He WT, Wan H, Hu L, Chen P, Wang X, Huang Z, et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1\u03b2 secretion. Cell Research. 2015; 25: 1285\u20131298.","DOI":"10.1038\/cr.2015.139"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nature Cell Biology. 2013; 15: 978\u2013990.","DOI":"10.1038\/ncb2784"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Paradies G, Paradies V, Ruggiero FM, Petrosillo G. Role of Cardiolipin in Mitochondrial Function and Dynamics in Health and Disease: Molecular and Pharmacological Aspects. Cells. 2019; 8: 728.","DOI":"10.3390\/cells8070728"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Chu CT, Ji J, Dagda RK, Jiang JF, Tyurina YY, Kapralov AA, et al. Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nature Cell Biology. 2013; 15: 1197\u20131205.","DOI":"10.1038\/ncb2837"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Shen Z, Ye C, McCain K, Greenberg ML. The Role of Cardiolipin in Cardiovascular Health. BioMed Research International. 2015; 2015: 891707.","DOI":"10.1155\/2015\/891707"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"Yakes FM, Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proceedings of the National Academy of Sciences of the United States of America. 1997; 94: 514\u2013519.","DOI":"10.1073\/pnas.94.2.514"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"Barnes RP, Fouquerel E, Opresko PL. The impact of oxidative DNA damage and stress on telomere homeostasis. Mechanisms of Ageing and Development. 2019; 177: 37\u201345.","DOI":"10.1016\/j.mad.2018.03.013"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Ota H, Akishita M, Eto M, Iijima K, Kaneki M, Ouchi Y. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. Journal of Molecular and Cellular Cardiology. 2007; 43: 571\u2013579.","DOI":"10.1016\/j.yjmcc.2007.08.008"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Kim WY, Sharpless NE. The regulation of INK4\/ARF in cancer and aging. Cell. 2006; 127: 265\u2013275.","DOI":"10.1016\/j.cell.2006.10.003"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Daigh LH, Saha D, Rosenthal DL, Ferrick KR, Meyer T. Uncoupling of mTORC1 from E2F activity maintains DNA damage and senescence. Nature Communications. 2024; 15: 9181.","DOI":"10.1038\/s41467-024-52820-6"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"Galloway CA, Yoon Y. Mitochondrial morphology in metabolic diseases. Antioxidants & Redox Signaling. 2013; 19: 415\u2013430.","DOI":"10.1089\/ars.2012.4779"},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"Bingol B, Tea JS, Phu L, Reichelt M, Bakalarski CE, Song Q, et al. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy. Nature. 2014; 510: 370\u2013375.","DOI":"10.1038\/nature13418"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Mengus C, Neutzner M, Bento ACPF, Bippes CC, Kohler C, Decembrini S, et al. VCP\/p97 cofactor UBXN1\/SAKS1 regulates mitophagy by modulating MFN2 removal from mitochondria. Autophagy. 2022; 18: 171\u2013190.","DOI":"10.1080\/15548627.2021.1922982"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"Sun N, Barta H, Chaudhuri S, Chen K, Jin J, Luo H, et al. Mitophagy mitigates mitochondrial fatty acid \u03b2-oxidation deficient cardiomyopathy. Nature Communications. 2025; 16: 5465.","DOI":"10.1038\/s41467-025-60670-z"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"Fonseka O, Raja R, Ross C, Gare SR, Zhang J, Hille SS, et al. XBP1s-EDEM2 Prevents the Onset and Development of HFpEF by Ameliorating Cardiac Lipotoxicity. Circulation. 2025; 151: 1583\u20131605.","DOI":"10.1161\/CIRCULATIONAHA.124.072194"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012; 149: 274\u2013293.","DOI":"10.1016\/j.cell.2012.03.017"},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"Porstmann T, Santos CR, Griffiths B, Cully M, Wu M, Leevers S, et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metabolism. 2008; 8: 224\u2013236.","DOI":"10.1016\/j.cmet.2008.07.007"},{"key":"ref97","doi-asserted-by":"publisher","unstructured":"Shimano H, Sato R. SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology. Nature Reviews. Endocrinology. 2017; 13: 710\u2013730.","DOI":"10.1038\/nrendo.2017.91"},{"key":"ref98","doi-asserted-by":"publisher","unstructured":"D\u00fcvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Molecular Cell. 2010; 39: 171\u2013183.","DOI":"10.1016\/j.molcel.2010.06.022"},{"key":"ref99","doi-asserted-by":"publisher","unstructured":"Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. The Journal of Clinical Investigation. 2002; 109: 1125\u20131131.","DOI":"10.1172\/JCI15593"},{"key":"ref100","doi-asserted-by":"publisher","unstructured":"Moon YA, Liang G, Xie X, Frank-Kamenetsky M, Fitzgerald K, Koteliansky V, et al. The Scap\/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals. Cell Metabolism. 2012; 15: 240\u2013246.","DOI":"10.1016\/j.cmet.2011.12.017"},{"key":"ref101","doi-asserted-by":"publisher","unstructured":"Wong LSM, de Boer RA, Samani NJ, van Veldhuisen DJ, van der Harst P. Telomere biology in heart failure. European Journal of Heart Failure. 2008; 10: 1049\u20131056.","DOI":"10.1016\/j.ejheart.2008.08.007"},{"key":"ref102","doi-asserted-by":"publisher","unstructured":"Owens WA, Walaszczyk A, Spyridopoulos I, Dookun E, Richardson GD. Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls. Mechanisms of Ageing and Development. 2021; 198: 111540.","DOI":"10.1016\/j.mad.2021.111540"},{"key":"ref103","doi-asserted-by":"publisher","unstructured":"Hoffmann J, Richardson G, Haendeler J, Altschmied J, Andr\u00e9s V, Spyridopoulos I. Telomerase as a Therapeutic Target in Cardiovascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2021; 41: 1047\u20131061.","DOI":"10.1161\/ATVBAHA.120.315695"},{"key":"ref104","doi-asserted-by":"publisher","unstructured":"Wang Z, Liu W, Zhang M, Yan J, Fei J, Zhang K, et al. Canthaxanthin Mitigates Cardiovascular Senescence in Vitro and in Vivo. Frontiers in Bioscience (Landmark edition). 2024; 29: 70.","DOI":"10.31083\/j.fbl2902070"},{"key":"ref105","doi-asserted-by":"publisher","unstructured":"Li R, Teng Y, Guo Y, Ren J, Li R, Luo H, et al. Aging-related decrease of histone methyltransferase SUV39H1 in adipose-derived stem cells enhanced SASP. Mechanisms of Ageing and Development. 2023; 215: 111868.","DOI":"10.1016\/j.mad.2023.111868"},{"key":"ref106","doi-asserted-by":"publisher","unstructured":"Wang B, Han J, Elisseeff JH, Demaria M. The senescence-associated secretory phenotype and its physiological and pathological implications. Molecular Cell Biology. 2024; 25: 958\u2013978.","DOI":"10.1038\/s41580-024-00727-x"},{"key":"ref107","doi-asserted-by":"publisher","unstructured":"Rea IM, Gibson DS, McGilligan V, McNerlan SE, Alexander HD, Ross OA. Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines. Frontiers in Immunology. 2018; 9: 586.","DOI":"10.3389\/fimmu.2018.00586"},{"key":"ref108","doi-asserted-by":"publisher","unstructured":"Ryczkowska K, Adach W, Janikowski K, Banach M, Bielecka-Dabrowa A. Menopause and women's cardiovascular health: is it really an obvious relationship? Archives of Medical Science: AMS. 2022; 19: 458\u2013466.","DOI":"10.5114\/aoms\/157308"},{"key":"ref109","doi-asserted-by":"publisher","unstructured":"Seeger T, Haffez F, Fischer A, Koehl U, Leistner DM, Seeger FH, et al. Immunosenescence-associated microRNAs in age and heart failure. European Journal of Heart Failure. 2013; 15: 385\u2013393.","DOI":"10.1093\/eurjhf\/hfs184"},{"key":"ref110","doi-asserted-by":"publisher","unstructured":"Shinmura K. Cardiac Senescence, Heart Failure, and Frailty: A Triangle in Elderly People. The Keio Journal of Medicine. 2016; 65: 25\u201332.","DOI":"10.2302\/kjm.2015-0015-IR"},{"key":"ref111","doi-asserted-by":"publisher","unstructured":"Copp\u00e9 JP, Patil CK, Rodier F, Sun Y, Mu\u00f1oz DP, Goldstein J, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biology. 2008; 6: 2853\u20132868.","DOI":"10.1371\/journal.pbio.0060301"},{"key":"ref112","doi-asserted-by":"publisher","unstructured":"Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell. 2008; 132: 363\u2013374.","DOI":"10.1016\/j.cell.2007.12.032"},{"key":"ref113","doi-asserted-by":"publisher","unstructured":"Kuilman T, Michaloglou C, Vredeveld LCW, Douma S, van Doorn R, Desmet CJ, et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell. 2008; 133: 1019\u20131031.","DOI":"10.1016\/j.cell.2008.03.039"},{"key":"ref114","doi-asserted-by":"publisher","unstructured":"Xu M, Pirtskhalava T, Farr JN, Weigand BM, Palmer AK, Weivoda MM, et al. Senolytics improve physical function and increase lifespan in old age. Nature Medicine. 2018; 24: 1246\u20131256.","DOI":"10.1038\/s41591-018-0092-9"},{"key":"ref115","doi-asserted-by":"publisher","unstructured":"Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nature Reviews. Endocrinology. 2018; 14: 576\u2013590.","DOI":"10.1038\/s41574-018-0059-4"},{"key":"ref116","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023; 186: 243\u2013278.","DOI":"10.1016\/j.cell.2022.11.001"},{"key":"ref117","doi-asserted-by":"publisher","unstructured":"Hua Y, Robinson TJ, Cao Y, Shi GP, Ren J, Nair S, et al. Cathepsin K knockout alleviates aging-induced cardiac dysfunction. Aging Cell. 2015; 14: 345\u2013351.","DOI":"10.1111\/acel.12276"},{"key":"ref118","doi-asserted-by":"publisher","unstructured":"Fang CL, Liu B, Wan M. \"Bone-SASP\" in Skeletal Aging. Calcified Tissue International. 2023; 113: 68\u201382.","DOI":"10.1007\/s00223-023-01100-4"},{"key":"ref119","doi-asserted-by":"publisher","unstructured":"Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa KI, Kitazawa R, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. The Journal of Clinical Investigation. 2006; 116: 1494\u20131505.","DOI":"10.1172\/JCI26498"},{"key":"ref120","doi-asserted-by":"publisher","unstructured":"Spinale FG. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiological Reviews. 2007; 87: 1285\u20131342.","DOI":"10.1152\/physrev.00012.2007"},{"key":"ref121","doi-asserted-by":"publisher","unstructured":"Luo Y, Yu Y, Zeng F, Yi Y, Lu Z, Lin B, et al. Acetylation of FABP3 alleviates radioimmunotherapy-induced cardiomyocyte senescence by modulating long-chain polyunsaturated fatty acid metabolism. International Immunopharmacology. 2025; 160: 114912.","DOI":"10.1016\/j.intimp.2025.114912"},{"key":"ref122","doi-asserted-by":"publisher","unstructured":"Childs BG, Durik M, Baker DJ, van Deursen JM. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nature Medicine. 2015; 21: 1424\u20131435.","DOI":"10.1038\/nm.4000"},{"key":"ref123","doi-asserted-by":"publisher","unstructured":"Chen GY, Nu\u00f1ez G. Sterile inflammation: sensing and reacting to damage. Nature Reviews. Immunology. 2010; 10: 826\u2013837.","DOI":"10.1038\/nri2873"},{"key":"ref124","doi-asserted-by":"publisher","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. The New England Journal of Medicine. 2020; 383: 1413\u20131424.","DOI":"10.1056\/NEJMoa2022190"},{"key":"ref125","doi-asserted-by":"publisher","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. The New England Journal of Medicine. 2015; 373: 2117\u20132128.","DOI":"10.1056\/NEJMoa1504720"},{"key":"ref126","doi-asserted-by":"publisher","unstructured":"de Souza SLB, Mota GAF, da Silva VL, Vileigas DF, Sant'Ana PG, Gregolin CS, et al. Effects of early exercise on cardiac function and lipid metabolism pathway in heart failure. Journal of Cellular and Molecular Medicine. 2023; 27: 2956\u20132969.","DOI":"10.1111\/jcmm.17908"},{"key":"ref127","doi-asserted-by":"publisher","unstructured":"Pradhan AD, Paynter NP, Everett BM, Glynn RJ, Amarenco P, Elam M, et al. Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study. American Heart Journal. 2018; 206: 80\u201393.","DOI":"10.1016\/j.ahj.2018.09.011"},{"key":"ref128","doi-asserted-by":"publisher","unstructured":"Goh KY, He L, Song J, Jinno M, Rogers AJ, Sethu P, et al. Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice. Redox Biology. 2019; 21: 101100.","DOI":"10.1016\/j.redox.2019.101100"},{"key":"ref129","doi-asserted-by":"publisher","unstructured":"Mingorance C, Rodriguez-Rodriguez R, Justo ML, Herrera MD, de Sotomayor MA. Pharmacological effects and clinical applications of propionyl-L-carnitine. Nutrition Reviews. 2011; 69: 279\u2013290.","DOI":"10.1111\/j.1753-4887.2011.00387.x"},{"key":"ref130","doi-asserted-by":"publisher","unstructured":"Chaurasia B, Summers SA. Ceramides in Metabolism: Key Lipotoxic Players. Annual Review of Physiology. 2021; 83: 303\u2013330.","DOI":"10.1146\/annurev-physiol-031620-093815"},{"key":"ref131","doi-asserted-by":"publisher","unstructured":"Xu M, Tchkonia T, Ding H, Ogrodnik M, Lubbers ER, Pirtskhalava T, et al. JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proceedings of the National Academy of Sciences of the United States of America. 2015; 112: E6301\u2013E6310.","DOI":"10.1073\/pnas.1515386112"},{"key":"ref132","doi-asserted-by":"publisher","unstructured":"Zhu Y, Tchkonia T, Pirtskhalava T, Gower AC, Ding H, Giorgadze N, et al. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell. 2015; 14: 644\u2013658.","DOI":"10.1111\/acel.12344"},{"key":"ref133","doi-asserted-by":"publisher","unstructured":"Roos CM, Zhang B, Palmer AK, Ogrodnik MB, Pirtskhalava T, Thalji NM, et al. Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice. Aging Cell. 2016; 15: 973\u2013977.","DOI":"10.1111\/acel.12458"},{"key":"ref134","doi-asserted-by":"publisher","unstructured":"Mourad O, Mastikhina O, Khan S, Sun X, Hatkar R, Williams K, et al. Antisenescence Therapy Improves Function in a Human Model of Cardiac Fibrosis-on-a-Chip. ACS Materials Au. 2023; 3: 360\u2013370.","DOI":"10.1021\/acsmaterialsau.3c00009"},{"key":"ref135","doi-asserted-by":"publisher","unstructured":"Butler J, Fioretti F, McMullan CJ, Anstrom KJ, Barash I, Bonaca MP, et al. Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial. European Heart Journal. 2026; 47: 683\u2013697.","DOI":"10.1093\/eurheartj\/ehaf655"},{"key":"ref136","doi-asserted-by":"publisher","unstructured":"Hao WR, Chen CC, Li FA, Chen HY, Liu JC, Cheng TH, et al. Therapeutic Impact of Vericiguat on Ventricular Remodeling in a Pressure-Overload Heart Failure Model. Life (Basel, Switzerland). 2025; 15: 1763.","DOI":"10.3390\/life15111763"},{"key":"ref137","doi-asserted-by":"publisher","unstructured":"Butler J, McMullan CJ, Anstrom KJ, Barash I, Bonaca MP, Borentain M, et al. Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial. Lancet (London, England). 2025; 406: 1341\u20131350.","DOI":"10.1016\/S0140-6736(25)01665-4"},{"key":"ref138","doi-asserted-by":"publisher","unstructured":"Chang J, Wang Y, Shao L, Laberge RM, Demaria M, Campisi J, et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nature Medicine. 2016; 22: 78\u201383.","DOI":"10.1038\/nm.4010"},{"key":"ref139","doi-asserted-by":"publisher","unstructured":"Zhu Y, Doornebal EJ, Pirtskhalava T, Giorgadze N, Wentworth M, Fuhrmann-Stroissnigg H, et al. New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463. Aging. 2017; 9: 955\u2013963.","DOI":"10.18632\/aging.101202"},{"key":"ref140","doi-asserted-by":"publisher","unstructured":"Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, et al. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. The New England Journal of Medicine. 2020; 382: 1883\u20131893.","DOI":"10.1056\/NEJMoa1915928"},{"key":"ref141","doi-asserted-by":"publisher","unstructured":"Ma J, Guo S, Jiang H, Li B. Efficacy and safety of vericiguat in heart failure: a meta-analysis. The Journal of International Medical Research. 2023; 51: 3000605231159333.","DOI":"10.1177\/03000605231159333"},{"key":"ref142","doi-asserted-by":"publisher","unstructured":"Packer M. Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling\/Autophagy Hypothesis. Circulation. 2022; 146: 1383\u20131405.","DOI":"10.1161\/CIRCULATIONAHA.122.061732"},{"key":"ref143","doi-asserted-by":"publisher","unstructured":"Triposkiadis F, Xanthopoulos A, Butler J. Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week. Journal of the American College of Cardiology. 2019; 74: 804\u2013813.","DOI":"10.1016\/j.jacc.2019.06.053"},{"key":"ref144","doi-asserted-by":"publisher","unstructured":"La Grotta R, Frig\u00e9 C, Matacchione G, Olivieri F, de Candia P, Ceriello A, et al. Repurposing SGLT-2 Inhibitors to Target Aging: Available Evidence and Molecular Mechanisms. International Journal of Molecular Sciences. 2022; 23: 12325.","DOI":"10.3390\/ijms232012325"},{"key":"ref145","doi-asserted-by":"publisher","unstructured":"Katsuumi G, Shimizu I, Suda M, Yoshida Y, Furihata T, Joki Y, et al. SGLT2 inhibition eliminates senescent cells and alleviates pathological aging. Nature Aging. 2024; 4: 926\u2013938.","DOI":"10.1038\/s43587-024-00642-y"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/9\/10.31083\/FBL48959","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:23:05Z","timestamp":1790698985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/9\/10.31083\/FBL48959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":145,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6698(26)03775-0"],"URL":"https:\/\/doi.org\/10.31083\/fbl48959","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"article-number":"48959"}}